{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:20:58Z","timestamp":1791310858303,"version":"4.3.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Genetics & Development"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.gde.2006.12.004","type":"journal-article","created":{"date-parts":[[2007,1,6]],"date-time":"2007-01-06T07:11:19Z","timestamp":1168067479000},"page":"15-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Deregulated Ras signaling in developmental disorders: new tricks for an old dog"],"prefix":"10.1016","volume":"17","author":[{"given":"Suzanne","family":"Schubbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Bollag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gde.2006.12.004_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","author":"Malumbres","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.gde.2006.12.004_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","article-title":"NF1 tumor suppressor gene function: narrowing the GAP","volume":"104","author":"Cichowski","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.gde.2006.12.004_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.genom.6.080604.162305","article-title":"Noonan syndrome and related disorders: genetics and pathogenesis","volume":"6","author":"Tartaglia","year":"2005","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.gde.2006.12.004_bib4_1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/ng1641","article-title":"Germline mutations in HRAS proto-oncogene cause Costello syndrome","volume":"37","author":"Aoki","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2006.12.004_bib5_1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ng1749","article-title":"Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome","volume":"38","author":"Niihori","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2006.12.004_bib6_1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome","volume":"311","author":"Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.gde.2006.12.004_bib7_1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2006.12.004_bib8_1","doi-asserted-by":"crossref","unstructured":"Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, Li L, Yassin Y, Tamburino AM, Neel BG et al: Germline gain-of-function mutations inSOS1cause Noonan syndrome.Nat Genet 2006, in press.","DOI":"10.1038\/ng1926"},{"key":"10.1016\/j.gde.2006.12.004_bib9_1","doi-asserted-by":"crossref","unstructured":"Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, Pandit B, Oishi K, Martinelli S, Schackwitz W et al: Gain-of-functionSOS1mutations cause a distinctive form of Noonan syndrome.Nat Genet 2006, in press.","DOI":"10.1038\/ng1939"},{"key":"10.1016\/j.gde.2006.12.004_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/366643a0","article-title":"Proteins regulating Ras and its relatives","volume":"366","author":"Boguski","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.gde.2006.12.004_bib11","first-page":"23","article-title":"GTPase activating proteins: critical regulators of intracellular signaling","volume":"1602","author":"Donovan","year":"2002","journal-title":"BBA Rev Cancer"},{"key":"10.1016\/j.gde.2006.12.004_bib12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1126\/science.1062023","article-title":"The guanine nucleotide-binding switch in three dimensions","volume":"294","author":"Vetter","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.gde.2006.12.004_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.gde.2006.12.004_bib14_1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.molcel.2006.05.011","article-title":"The kelch proteins Gpb1 and Gpb2 inhibit Ras activity via association with the yeast RasGAP neurofibromin homologs Ira1 and Ira2","volume":"22","author":"Harashima","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.gde.2006.12.004_bib15","first-page":"2378","article-title":"The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice","volume":"116","author":"Ismat","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gde.2006.12.004_bib16","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-04-4058","article-title":"Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.gde.2006.12.004_bib17","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2006.12.004_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2006.12.004_bib19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","article-title":"The \u2018Shp\u2019ing news: SH2 domain-containing tyrosine phosphatases in cell signaling","volume":"28","author":"Neel","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.gde.2006.12.004_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/MCB.20.1.299-311.2000","article-title":"Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps","volume":"20","author":"O\u2019Reilly","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.gde.2006.12.004_bib21_1","doi-asserted-by":"crossref","first-page":"30984","DOI":"10.1074\/jbc.M504699200","article-title":"Diverse biochemical properties of Shp2 mutants: Implications for disease phenotypes","volume":"280","author":"Keilhack","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gde.2006.12.004_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/pbc.20644","article-title":"Inherited predispositions and hyperactive Ras in myeloid leukemogenesis","volume":"46","author":"Lauchle","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.gde.2006.12.004_bib23","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2005-02-0531","article-title":"The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome\/myeloproliferative disease","volume":"106","author":"Kratz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.gde.2006.12.004_bib24","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2003-09-3287","article-title":"Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis","volume":"103","author":"Loh","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.gde.2006.12.004_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2006.12.004_bib26","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1182\/blood-2004-10-4002","article-title":"Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte\u2013macrophage colony-stimulating factor","volume":"105","author":"Chan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.gde.2006.12.004_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccr.2005.01.010","article-title":"Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations","volume":"7","author":"Mohi","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gde.2006.12.004_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2004-11-4207","article-title":"Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells","volume":"106","author":"Schubbert","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.gde.2006.12.004_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm1084","article-title":"Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation","volume":"10","author":"Araki","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.gde.2006.12.004_bib30_1","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.M513068200","article-title":"PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects","volume":"281","author":"Kontaridis","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gde.2006.12.004_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/499925","article-title":"Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease","volume":"78","author":"Tartaglia","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2006.12.004_bib32","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.febslet.2006.03.088","article-title":"Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1","volume":"580","author":"Hanna","year":"2006","journal-title":"FEBS Letters"},{"key":"10.1016\/j.gde.2006.12.004_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.a.31078","article-title":"HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy","volume":"140","author":"Estep","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.gde.2006.12.004_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.a.31047","article-title":"HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation","volume":"140","author":"Gripp","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.gde.2006.12.004_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1086\/504394","article-title":"Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype","volume":"79","author":"Carta","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2006.12.004_bib36","article-title":"The cardio-facio-cutaneous (CFC) syndrome: a review","author":"Roberts","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.gde.2006.12.004_bib37","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.gde.2006.12.004_bib38_1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","article-title":"Mechanism of activation of the RAF\u2013ERK signaling pathway by oncogenic mutations of B-RAF","volume":"116","author":"Wan","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.gde.2006.12.004_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nm0306-283","article-title":"Stops along the RAS pathway in human genetic disease","volume":"12","author":"Bentires-Alj","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.gde.2006.12.004_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood-2003-11-3876","article-title":"Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia","volume":"104","author":"Tartaglia","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.gde.2006.12.004_bib41","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1158\/0008-5472.CAN-04-1923","article-title":"Activating mutations of the Noonan syndrome-associated SHP2\/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia","volume":"64","author":"Bentires-Alj","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.gde.2006.12.004_bib42","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/MCB.21.5.1444-1452.2001","article-title":"Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development","volume":"21","author":"Esteban","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.gde.2006.12.004_bib43","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1101\/gad.11.19.2468","article-title":"K-ras is an essential gene in the mouse with partial functional overlap with N-ras","volume":"11","author":"Johnson","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.gde.2006.12.004_bib44","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1073\/pnas.92.5.1709","article-title":"The murine N-ras gene is not essential for growth and development","volume":"92","author":"Umanoff","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2006.12.004_bib45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1535-6108(04)00085-6","article-title":"Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects","volume":"5","author":"Tuveson","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gde.2006.12.004_bib46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1146\/annurev.immunol.24.021605.090723","article-title":"Compartmentalized Ras\/MAPK signaling","volume":"24","author":"Mor","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.gde.2006.12.004_bib47","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.molcel.2006.02.011","article-title":"Differential modification of Ras proteins by ubiquitination","volume":"21","author":"Jura","year":"2006","journal-title":"Mol Cell"}],"container-title":["Current Opinion in Genetics & Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X06002395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X06002395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:33:12Z","timestamp":1760700792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959437X06002395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0959437X06002395"],"URL":"https:\/\/doi.org\/10.1016\/j.gde.2006.12.004","relation":{},"ISSN":["0959-437X"],"issn-type":[{"value":"0959-437X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deregulated Ras signaling in developmental disorders: new tricks for an old dog","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Genetics & Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gde.2006.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}